baber/WOPTO huggingface dataset:
Patent AU-3892100-A (AU)
Title: System for indexing pedestrian traffic
Inventor: KRAMERICH GEORGE
IPC: G06Q30/02
Filed: 2000-03-17
Abstract: A system and a method for indexing pedestrian traffic are disclosed. Traffic information is gathered from counter units ( 30, 31 ) placed at entrances in provider malls, retail stores, or other locations where pedestrians may be counted. The counters give daily reports to the traffic indexing system ( 40 ) of the amount of pedestrian traffic flowing through traffic monitoring points ( 30, 31 ). Traffic data are collected daily from providers and compiled into an index ( 40 ). These data may be integrated and indexed with other data such as sales data, labor data and promotion data. Providers ( 30, 31 ) and other users ( 45 ) may access the traffic index ( 40 ) along with other industry information to gauge their performance as compared to the performance of others in the industry or to make educated decisions on development and marketing issues.
Patent AU-3935593-A (AU)
Title: Calanolide antiviral compounds, compositions and uses thereof
Inventor: BOYD MICHAEL R
IPC: A61P31/12
Filed: 1993-03-24
Abstract: The present invention provides novel antiviral compounds, refered to as calanolides, and their derivatives of formulae (I) and (II) which may be isolated from plants of the genus Calophyllum in accordance with the present inventive method. The compounds and their derivatives may be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the growth or replication of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2.
Patent AU-4041995-A (AU)
Title: Immunogenic hybrid protein OprF-OprL derived from Pseudomonas aeruginosa membrane proteins
Inventor: KNAPP BERNHARD DR
IPC: C12N15/31
Filed: 1995-12-14
Abstract: The present invention relates to a hybrid protein comprising the Pseudomonas aeruginosa outer membrane protein I (OprI) which is fused with its amino terminal end to the carboxy-terminal end of a carboxy-terminal portion of the Pseudomonas aeruginosa outer membrane protein F (OprF), as well as to monoclonal or polyclonal antibodies against this hybrid protein. Both, the hybrid protein and the antibodies directed to the hybrid protein confer protection against an infection by Pseudomonas aeruginosa to laboratory animals or man.
Patent AU-4078193-A (AU)
Title: Crepe effect bandage
Inventor: EVANS JOHN CHRISTOPHER
IPC: D02G3/44
Filed: 1993-05-10
Abstract: PCT No. PCT/GB93/00958 Sec. 371 Date Nov. 7, 1994 Sec. 102(e) Date Nov. 7, 1994 PCT Filed May 10, 1993 PCT Pub. No. WO93/22994 PCT Pub. Date Nov. 25, 1993There is described a woven bandage which exhibits a crepe effect and which contains composite warp yarns (1) and weft filaments (7) wherein the composite warp yarns (1) are formed by twisting a staple fiber yarn (2) and a textured filament yarn (3) together. The staple fiber yarn (2) forms loops (4) which gives the bandage a crepe effect. There is also described a process for the manufacture of such woven bandages and an article of manufacture which includes the composite warp yarns used in the woven bandage.
Patent AU-4080399-A (AU)
Title: Prevention and treatment of hypergastrinemia
Inventor: GEVAS PHILIP C
IPC: C07K16/40
Filed: 1999-05-14
Abstract: Serum-associated hypergastrinemia is treated by administration of gastrin active or passive immunization. An anti-gastrin immunogenic composition containing a gastrin G17 or G34 peptide fragment which is amino acid spacer-linked to an immunogenic carrier, is administered so as to effectively neutralize the circulating gastrin hormone, and moreover, inhibit autocrine activity by progastrin such as Gly-extended G17, and amidated G17, in patients with pernicious anemia. Moreover, the method includes administration of a therapeutically effective amount of anti-G17 or anti-G34 antibodies which may be in humanized form. Finally, the method provides ameliorating treatment of hypergastrinemic effects of proton pump inhibitors or H<SUB>2 </SUB>histamine receptor blocking agents or antagonists, in addition to treatment of hypergastrinemia caused by diseases such as pernicious anemia.
Patent AU-4142801-A (AU)
Title: Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
Inventor: WOO LECON
IPC: A61M1/02
Filed: 2001-01-26
Abstract: A device and method for inactivating pathogens in therapeutic fluids with sterilizing radiation in a continuous thin fluid flow arrangement that exhibits radiation dose uniformity for fluids having high optical densities. Radiation dose uniformity is achieved in part through a "carrying" mechanism that moves or carries the fluid, thereby eliminating a channel flow velocity profile where flow volumes near the channel walls run the risk of overexposure to the radiation due to very large residence times within the channel. The device comprises a relatively flat belt chamber (22) connected to a fluid flow through an inlet (24) and an outlet (26) on the belt chamber (22). The belt chamber (22) has a top surface (28) and a bottom surface (30). A radiation permeable plate (32) is disposed adjacent the top surface (28) of the belt chamber (22) and is in contact with the belt chamber (22). A radiation source (42) is provided adjacent to the plate (32) adjacent to a side opposite the belt chamber (22). A belt (34) having a plurality of flexible vanes (36) is disposed adjacent the bottom surface (30) of the belt chamber (22) such that the vanes (36) make contact with the belt chamber (22). The belt is driven by a roller mechanism (38) in the direction of the fluid flow. As the fluid flows through the belt chamber (22), the flexible vanes (36) provide a squeegee-like mechanism to move the fluid through the belt chamber (22) in discrete packets (40) defined by a pair of vanes (36). As the packets of fluid move through the belt chamber, they are exposed to sterilizing radiation passing through the plate (32).
Patent AU-4163199-A (AU)
Title: Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
Inventor: VERONESI PAOLO ALBERTO
IPC: A61K47/48
Filed: 1999-05-20
Abstract: A compound of general formula: <?in-line-formulae description="In-line Formulae" end="lead"?>[CH<SUB>3</SUB>O-(CH<SUB>2</SUB>-CH<SUB>2</SUB>-O)<SUB>n</SUB>-CH<SUB>2</SUB>-CH<SUB>2</SUB>]<SUB>x</SUB>-(NH)<SUB>y</SUB>Lysozyme c. (Z)<SUB>m </SUB><?in-line-formulae description="In-line Formulae" end="tail"?> wherein: y is the number of free amino groups of lysine molecules present in the molecule of lysozyme c; x is comprised between 1 and y; n is comprised between 5 and 1000; Z is a pharmaceutically acceptable acid; m is comprised between 1 and y.
Patent AU-4252393-A (AU)
Title: Telecommunication device for the deaf with interrupt and pseudo-duplex capability
Inventor: ENGELKE ROBERT M
IPC: H04M11/06
Filed: 1993-05-19
Abstract: A telecommunication device for the deaf operates under conventional Baudot communication protocol, but has enhanced features enabling it to handle interrupts either from a conventional or a similar TDD. The improved TDD is also capable of pseudo-duplex communication with a similar TDD in which each device transmits packets of characters alternatively to the other thus making it appear to the users that simultaneous transmission is occurring. The implementation of these features is done in such a way that the TDD is fully capable of communication with existing TDD devices and the device obeys normals rules and conventions for Baudot communication.
Patent AU-4316497-A (AU)
Title: Stamper for two layered disc
Inventor: JENKINS HAROLD
IPC: G11B7/24038
Filed: 1997-09-05
Abstract: Because of peculiarities of the second layer of the DVD compact disc a Mother is used as a Stamper to replicate the proper pit structure and sequence. This has the advantages of incurring no additional cost at Mastering or Plating other than the cost of replicating additional Mothers, and of allowing the manufacturer to use either layer of data as the upper or lower DVD layer.
Patent AU-4360185-A (AU)
Title: Stabilising polymers and polymer films
Inventor: POYNER WILLIAM RAYMOND
IPC: C08K5/00
Filed: 1985-06-12
Abstract: @ A composition which comprises a polymer and a nickel dialkyldithiocarbamate of the formula (R'RZNCSS)<sub>2</sub>Ni, wherein R<sup>1</sup> and R<sup>2</sup> are the same or different branched-chain C<sub>5-18</sub> alkyl groups. Such a composition, which preferably additionally comprises a zinc dialkyldithiocarbamate, can be used, e.g. in film or sheet form, to protect flora at an agricultural or horticultural locus.
Patent AU-4490793-A (AU)
Title: Textured softgels
Inventor: BEZAIRE OVILA
IPC: B29C43/08
Filed: 1993-08-25
Abstract: A softgel having a texture on at least a portion of its surface and a process and apparatus for the manufacture thereof. The process for manufacturing the textured softgel includes forming a flowable gelatin mass, providing a rotary drum having an outer surface, controllably directing a flowable gelatin mass to the outer surface of the drum, forming a gelatin ribbon of substantially uniform thickness on the outer surface of the drum, the gelatin ribbon being initially in a relatively softer and moldable state immediately following the directing step, providing a roller of reduced diameter with a textured surface closely adjacent to the outer surface of the drum, passing the ribbon while in the relatively softer and moldable state between the drum surface and the textured surface while applying sufficient pressure to the roller in the direction towards the drum to cause the textured surface to impart a matching texture on the other surface of the ribbon, providing a second gelatin ribbon, forming a plurality of filled softgels from the gelatin ribbons, the matching texture defining the outer surface of at least of a portion of each of the softgels.
Patent AU-4633385-A (AU)
Title: Loran c cycle slip reduction technique
Inventor: EDWARD MENICK RALPH
IPC: H03K5/13
Filed: 1985-06-24
Abstract: In accordance with the present invention, there is provided a Loran C cycle slip reduction technique that consists of sensing the signal to noise ratio and narrowing the phase locked loop bandwidth when a predetermined signal-to-noise threshold is exceeded.
Patent AU-4718193-A (AU)
Title: Ink jet printers and methods for their operation
Inventor: STAMER MICHAEL E
IPC: B41J2/075
Filed: 1993-07-28
Abstract: Flight time of a stream of ink drops is measured and compared against a set point to determine variations therefrom. Variations due to changes in the ink composition are compensated for by adding or withholding solvent in proportion to the detected change. Changes due to variations in nozzle drive voltage result in the computation and use of a new flight time set point value, if necessary to avoid erroneous corrective action.
Patent AU-4828099-A (AU)
Title: Fitness assay and associated methods
Inventor: ERICKSON JOHN W
IPC: A61K31/34
Filed: 1999-06-23
Abstract: The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy.
Patent AU-4915100-A (AU)
Title: Slotted closing valve for openings of containers
Inventor: HINS JOHANNES
IPC: B65D47/20
Filed: 2000-05-02
Abstract: A slit closure valve for container openings includes a membrane member of flexible material having an at least unidirectionally aligned slit-like outlet opening and a base member peripherally surrounding the membrane member and connected to the membrane member. The outlet opening is held in its closed position by the resilient properties of the material although it is adapted to be moved into its open position against the resilient bias force of the material by a predetermined differential positive pressure exerted on one side of the membrane member. A peripheral wall portion of the base member and an adjacent wall portion of the membrane member include therebetween an acute angle of less than 90'. At least one further, substantially peripherally aligned slit-like passage opening held in its closed position by the resilient properties of the material is provided in the membrane wall portion near the base member, said passage opening being adapted to be moved into its unblocking position by a differential negative pressure exerted on the membrane member from the side thereof subjected to said predetermined differential positive pressure. The valve thereby enables the pressure between the interior of a container and its surroundings to be equalized thus assisting in the restoration of the container after its walls have been pressed-in manually for emptying the contents of the container.
Patent AU-4982799-A (AU)
Title: Polishing pads for a semiconductor substrate
Inventor: ANJUR SRIRAM P
IPC: B24D3/32
Filed: 1999-07-08
Abstract: A polishing pad for polishing a semiconductor wafer which includes an open-celled, porous substrate having sintered particles of synthetic resin. The porous substrate is a uniform, continuous and tortuous interconnected network of capillary passage. The pores of the porous substrate have an average pore diameter of from about 5 to about 100 microns which enhances pad polishing performance.
Patent AU-5003099-A (AU)
Title: Biodegradable compositions for the controlled release of encapsulated substances
Inventor: SANKARAM MANTRIPRAGADA
IPC: A61K9/26
Filed: 1999-07-16
Abstract: Pharmaceutical compositions that enable the release of a physiologically active substance over a prolonged period of time following administration to a patient are described. The pharmaceutical compositions are provided by encapsulation of a physiologically active substance into a matrix comprising biodegradable polymers and lipids. The rate of release of the physiologically active substance from the pharmaceutical composition is controlled by varying the ratio of the polymer to the lipid. The compositions can be stored in an aqueous suspension or as a solid dosage form. The physiologically active substances include small molecules, peptides, proteins, nucleic acids and vaccines. The biodegradable polymers include homopolymers, or random or block copolymers. The lipids include phospholipids, cholesterol and glycerides.
Patent AU-5156990-A (AU)
Title: Centering and levelling of mobile press bending apparatus
Inventor: ENK ALLAN T
IPC: C03B23/03
Filed: 1990-02-14
Abstract: The invention pertains to a press bending apparatus incorporated in a mobile carriage mounted upon retractable wheels adapted to be carried upon rails extending transversely of the production line whereby it can be readily moved into and out of operative position in the line. Mechanism is included for vertically moving the carriage between a raised transport position and a lowered operating position. Centering and levelling means are provided for assuring proper alignment of the press members and associated conveyor rolls with the adjacent heating and tempering sections as the apparatus is moved into operating position.
Patent AU-5307596-A (AU)
Title: Gel and cushioning devices
Inventor: ARBOGAST ROBERT E
IPC: A61F2/50
Filed: 1996-03-20
Abstract: The invention relates to a polymeric gel and various articles of manufacture such as a cushion liner, a cushion locking liner, an open-ended cushion knee or elbow sleeve, and a cushion flat sheet, all useful for increasing the comfort of the wearer. Also described are sleeve members and liners for enclosing an amputation stump. The polymeric gel composition preferably comprises a block copolymer and mineral oil.
Patent AU-5339896-A (AU)
Title: Botulinum toxin derivatives able to modify peripheral sensory afferent functions
Inventor: FOSTER KEITH ALAN
IPC: A61K47/48
Filed: 1996-04-16
Abstract: A novel agent for the targeted control of a mammalian cell activity can be used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E, linked together in the following manner: Domain B-Domain T-Domain E where Domain B is the Binding Domain, which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome; Domain T is the Translocation Domain, which translocates the agent from within the endosome across the endosomal membrane into the cytosol of the cell; and Domain E is the Effector Domain, which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
Patent AU-5498596-A (AU)
Title: Storage medium unit for storing information data, preferably video data and/or audio data
Inventor: VOS JOHAN DE
IPC: H04N7/173
Filed: 1996-03-28
Abstract: The present invention provides a storage medium unit, comprising:      storage means for storing information data; table means for memorizing data which represent a relation between routing information and said information data; memory means for storing program data for controlling the operation of the storage medium unit; control means for controlling the storage means, the table means and the memory means according to the program data; and at least one interface for transmitting the information data with the routing information for such information data in the form of a packet to routing means.   <IMAGE>
Patent AU-5865290-A (AU)
Title: Modified biologically active protein
Inventor: MIZUSHIMA YUTAKA
IPC: C07F9/10
Filed: 1990-07-04
Abstract: A modified biologically active protein consisting essentially of a biologically active protein bonded to lecithin via a chemical linkage.
Patent AU-6120998-A (AU)
Title: Novel bicyclonucleoside and oligonucleotide analogue
Inventor: IMANISHI TAKESHI
IPC: A61K31/70
Filed: 1998-03-09
Abstract: An oligo- or polynucleotide analogue having one or more structures of the general formula   
where B is a pyrimidine or purine nucleic acid base, 
or an analogue thereof, 
is disclosed. The use of this analogue provides an oligonucleotide analogue antisense molecule, which is minimally hydrolyzable with an enzyme in vivo, has a high sense strand binding ability, and is easily synthesized.
Patent AU-6387096-A (AU)
Title: Oxidant scavengers
Inventor: TROVA MICHAEL P
IPC: A61K38/00
Filed: 1996-06-07
Abstract: The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating intra- and extracellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
Patent AU-6442794-A (AU)
Title: Titanium dioxide dispersions, cosmetic compositions and methods for using the same
Inventor: ZECCHINO JULIUS R
IPC: A61K8/04
Filed: 1994-02-25
Abstract: A novel organic dispersion comprises microfine titanium dioxide and a suitable branched chain organic without the use of any dispersing agent. The novel dispersion provide uniquely high SPF with low levels of dry weight titanium dioxide. Methods for preparing said dispersion and cosmetic sunscreen compositions comprising said dispersion are also included within the invention.
Patent AU-6682794-A (AU)
Title: Burner system
Inventor: WILLIAMSON MARK
IPC: F23D14/58
Filed: 1994-05-05
Abstract: A gas burner system which can be used in a conveyor-type oven has a burner tube (4) extending across the conveyor. Gas is burnt through a slot (8) along the tube to give a ribbon flame. The tube (4) is divided into separate compartments (15-19) which connect with different lengths of the slot (8). Combustible gas is fed under independent control to the different compartments (15-19), and the slot lengths are adjustable. The slot lengths consist of short edge-region slots and multiple, longer central region slots.
Patent AU-6696900-A (AU)
Title: Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
Inventor: RAPP HORST
IPC: A61P31/00
Filed: 2000-07-21
Abstract: The invention concerns the use of tosylchloramide(s), tosylchloramide salt(s), their derivatives and/or the decomposition products for treating diseases of the skin, mucous membranes, organs and tissues, excluding treatment of retroviral diseases (HIV) and disinfecting processes. It has been shown that tosylchloramide compounds can be used even for all diseases of the skin and viral mucosa causing formation of vesicles and itching, and they can lead to similar results as those obtained when they are used to treat corresponding diseases in tissues and organs. They not only provide quick relief of the acute symptoms and cure, but they also reduce frequency of recurrence. The inventive use is characterised in that it leads to very good treatment results, entirely independently of the form of preparation used, and it does not have to be administered in one specific manner. Relatively low amounts of tosylchloramide active principle can provide complete cure.
Patent AU-6719894-A (AU)
Title: Method and instrument for establishing the receiving site of a coronary artery bypass graft
Inventor: RYGAARD JAERGEN A
IPC: A61B17/30
Filed: 1994-04-12
Abstract: PCT No. PCT/DK94/00148 Sec. 371 Date Aug. 22, 1996 Sec. 102(e) Date Aug. 22, 1996 PCT Filed Apr. 12, 1994 PCT Pub. No. WO95/17127 PCT Pub. Date Jun. 29, 1995A method of locating a constriction in a coronary artery and performing an arteriotomy distally thereof which comprises locating the site of a constriction in a coronary artery by scanning the artery with a non-invasive sensing instrument capable of detecting the constriction. The sensing instrument has associated therewith a cutting instrument comprised of a cutter and member for moving the cutter into a position for making an incision. After the constriction is located, the cutting member is moved into a cutting position distal of the constriction and an incision is made through the wall of the artery into the lumen thereof.
Patent AU-6736896-A (AU)
Title: Pneumatically operated massaging cushion
Inventor: CENGARLE FRANCO
IPC: A61H23/04
Filed: 1996-07-22
Abstract: A pneumatically operated massaging cushion characterised by comprising: a compressor (16), a cyclic distributor (14) fed by said compressor (16) and provided with a plurality of exits (13), at least one manifold (6) comprising a plurality of longitudinal ducts (8) connected to the different exits (13) of said cyclic distributor (14), a plurality of side by side transverse compartments (2) inflatable independently of each other, means (10) for the individual connection of each of said transverse compartments (2) to one of said longitudinal ducts (8), the connections between the longitudinal ducts (8) of said manifold (6) and the exits (13) of said cyclic distributor (14) and between said transverse compartments (2) and said longitudinal ducts of said manifold (6) being such as to ensure the operation and the temporary and successive inflation of the adjacent transverse compartments.
Patent AU-6864200-A (AU)
Title: Control program product and data processing system
Inventor: SATO TOMOYOSHI
IPC: G06F9/38
Filed: 2000-08-30
Abstract: In the present invention, an input and/or output interface of at least one of a plurality of processing units forming a data processing system is designated independently of timing of execution of the processing unit, so as to allow the plurality of processing units to define various data paths at the program level. The present invention makes it possible to flexibly execute individual complicated data processes with hardware at a high speed without having various dedicated circuits fixed specifically to the respective data processings. <IMAGE>